LMLLF / PharmaDrug to Present at Wall Street Reporter's "Next Super Stock" Livestream Conference on Tuesday January 25, 2022

PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) announced that it will acquire all of the issued and outstanding shares of Securedose Synthetics Inc, a privat more_horizontal

PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) (PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF), PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF)). said it will consolidate its more_horizontal

PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF). said it will consolidate its common shares on a seven-to-one basis from October 24, 2023, and that the record more_horizontal

PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) said it continues to advance its patented reformulated enteric-coated version of orally bioavailable cepharanth more_horizontal

PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) announced it has appointed seasoned entrepreneur Robert Steen as its new CEO and chairman of the Board of Direc more_horizontal

PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) has announced a $300,000 investment in its Sairiyo Therapeutics biotech subsidiary by PharmaTher Inc, a wholly- more_horizontal

PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) announced the addition of David Posner to its advisory committee and as a consultant with a mandate for strateg more_horizontal

PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) announced that it has entered into a research collaboration agreement with PharmaTher Holdings Ltd to evaluate more_horizontal